Johnson & Johnson’s Price Target Cut at UBS (JNJ)

By
A A A
Share |

Healthcare products maker Johnson & Johnson ( JNJ ) on Wednesday saw its price target lowered by analysts at UBS.

The firm said it cut its target for JNJ to $74, which suggests a nearly 13% upside to the stock's Tuesday closing price of $65.77. UBS said it made the move due to lower recent market multiples in the healthcare space, but maintained its "Buy" rating.

Johnson & Johnson shares posted modest gains in premarket trading Wednesday.

The Bottom Line
Shares of Johnson & Johnson ( JNJ ) have a 3.47% dividend yield, based on last night's closing stock price of $65.77. The stock has technical support in the $60-$62 price area. If the shares can firm up, we see overhead resistance around the $66-$68 price levels.

Johnson & Johnson ( JNJ ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: JNJ

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

80%

Most Active by Volume

48,099,947
  • $16.09 ▲ 0.50%
40,277,806
  • $102.50 ▲ 0.24%
40,236,499
  • $19.57 ▲ 2.35%
31,092,510
  • $49.75 ▲ 0.65%
30,795,218
  • $34.92 ▲ 0.78%
29,910,855
  • $3.63 ▲ 0.83%
24,019,154
  • $13.06 ▼ 0.38%
23,753,906
  • $74.82 ▲ 1.31%
As of 8/29/2014, 04:04 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com